These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24609716)

  • 1. Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate.
    Lopalco G; Rigante D; Vitale A; Frediani B; Iannone F; Cantarini L
    Clin Rheumatol; 2015 Apr; 34(4):807-9. PubMed ID: 24609716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
    La Torre F; Muratore M; Vitale A; Moramarco F; Quarta L; Cantarini L
    Rheumatol Int; 2015 Nov; 35(11):1943-7. PubMed ID: 26048626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canakinumab for the treatment of TNF-receptor associated periodic syndrome.
    La Torre F; Caparello MC; Cimaz R
    Expert Rev Clin Immunol; 2017 Jun; 13(6):513-523. PubMed ID: 28454496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutation identified in severe early-onset tumor necrosis factor receptor-associated periodic syndrome: a case report.
    Radhakrishna SM; Grimm A; Broderick L
    BMC Pediatr; 2017 Apr; 17(1):108. PubMed ID: 28427379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent abdominal pain as the presentation of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in an Asian girl: a case report and review of the literature.
    Chen YJ; Yu HH; Yang YH; Lau YL; Lee WI; Chiang BL
    J Microbiol Immunol Infect; 2014 Dec; 47(6):550-4. PubMed ID: 22921805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case Presenting with the Clinical Characteristics of Tumor Necrosis Factor (TNF) Receptor-associated Periodic Syndrome (TRAPS) without TNFRSF1A Mutations Successfully Treated with Tocilizumab.
    Hosoya T; Mizoguchi F; Hasegawa H; Miura K; Koike R; Kubota T; Miyasaka N; Kohsaka H
    Intern Med; 2015; 54(16):2069-72. PubMed ID: 26278305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the diagnosis and treatment of tumor necrosis factor receptor-associated periodic syndrome.
    Aguado-Gil L; Irarrazaval-Armendáriz I; Pretel-Irazabal M
    Actas Dermosifiliogr; 2013 Sep; 104(7):617-22. PubMed ID: 23891452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of canakinumab for mosaic tumor necrosis factor receptor associated periodic syndrome.
    Terré A; Vautier M; Kahn JE; Georgin-Lavialle S; Boursier G
    Eur J Intern Med; 2024 May; 123():156-158. PubMed ID: 38307733
    [No Abstract]   [Full Text] [Related]  

  • 9. The First Case of a Korean Patient with a Mutation-Confirmed Tumor Necrosis Factor Receptor-Associated Periodic Syndrome.
    Lee SJ; Baek JY; Lee JY; Kang JM; Ahn JG
    Yonsei Med J; 2024 Apr; 65(4):241-245. PubMed ID: 38515362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting TNF Receptor-Associated Periodic Syndrome (TRAPS): Current Perspectives.
    Cudrici C; Deuitch N; Aksentijevich I
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in classification and treatment for TNF receptor-associated periodic syndrome].
    Tsukamoto H; Ueda N; Horiuchi T
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):361-8. PubMed ID: 22041423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trapped without a diagnosis: Tumour necrosis factor receptor-associated periodic syndrome (TRAPS).
    Kirresh A; Everitt A; Kon OM; DasGupta R; Pickering MC; Lachmann HJ
    Pract Neurol; 2016 Aug; 16(4):304-7. PubMed ID: 26965498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic literature review of efficacy/effectiveness and safety of current therapies for the treatment of cryopyrin-associated periodic syndrome, hyperimmunoglobulin D syndrome and tumour necrosis factor receptor-associated periodic syndrome.
    Kuemmerle-Deschner JB; Gautam R; George AT; Raza S; Lomax KG; Hur P
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32723831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different presentations in patients with tumor necrosis factor receptor-associated periodic syndrome mutations: report of two cases.
    Celebi-Tayfur A; Bilginer Y; Finetti M; Gattorno M; Ozen S
    Turk J Pediatr; 2013; 55(1):78-81. PubMed ID: 23692837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumor necrosis receptor associated periodic syndrome (TRAPS): State of the art].
    Georgin-Lavialle S; Kone-Paut I; Delaleu J; Sarrabay G; Grateau G; Touitou I; Hentgen V
    Rev Med Interne; 2018 Apr; 39(4):256-264. PubMed ID: 29525418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and clinical spectrum of four pedigrees of TRAPS in Greece: results from a national referral center.
    Nezos A; Argyropoulou OD; Klinaki E; Marketos N; Karagianni P; Eliopoulos E; Vlachoyiannopoulos P; Maritsi DN; Tzioufas AG
    Rheumatology (Oxford); 2020 Jun; 59(6):1241-1246. PubMed ID: 31562507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor receptor-associated periodic syndrome in a pediatric patient: A genetic diagnosis.
    Yakhmi N; Knutsen AP
    Ann Allergy Asthma Immunol; 2020 Oct; 125(4):369-371. PubMed ID: 32376455
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumour necrosis factor receptor-associated periodic syndrome caused by a rare mutation in the TNFRSF1A gene, and with excellent response to etanercept treatment.
    Cantarini L; Lucherini OM; Galeazzi M; Fanti F; Simonini G; Baldari CT; Laghi Pasini F; De Martino M; Cimaz R
    Clin Exp Rheumatol; 2009; 27(5):890-1. PubMed ID: 19917181
    [No Abstract]   [Full Text] [Related]  

  • 19. Delights and let-downs in the management of tumor necrosis factor receptor-associated periodic syndrome: the canakinumab experience in a patient with a high-penetrance T50M TNFRSF1A variant.
    Cantarini L; Lopalco G; Vitale A; Caso F; Lapadula G; Iannone F; Galeazzi M; Rigante D
    Int J Rheum Dis; 2015 May; 18(4):473-5. PubMed ID: 25522898
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor necrosis factor receptor-associated periodic fever syndrome in a 58-year-old man: caution not to discount TRAPS as a diagnosis in older patients.
    Sinožić D; Toplak N; Milotić I
    J Clin Rheumatol; 2011 Sep; 17(6):325-8. PubMed ID: 21869706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.